Ticker
SGMOCompany Name
SANGAMO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Capital Expenditure | Capital Expenditures Coverage | Net Cash Flow - Operations |
---|---|---|---|
6/30/2025 | $ 291K | 0 | $ -35.9M |
3/31/2025 | $ 267K | 0 | $ -44.63M |
12/31/2024 | $ 267K | 0 | $ -67.14M |
9/30/2024 | $ 2.79M | 0 | $ -114.33M |
6/30/2024 | $ 5.42M | 0 | $ -173.38M |
3/31/2024 | $ 10.96M | 0 | $ -207.21M |
12/31/2023 | $ 21.16M | 0 | $ -224.84M |
9/30/2023 | $ 25.96M | 0 | $ -231.35M |
6/30/2023 | $ 27.63M | 0 | $ -237.68M |
3/31/2023 | $ 27.53M | 0 | $ -230.95M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / CapEx
(=) CapEx Coverage
CapEx Coverage for SANGAMO THERAPEUTICS INC is calculated as follows: CF - Operations [ $ 153.35M ] / CapEx [ $ 17.48M ]
(=) CapEx Coverage [ 8.77 ]
Minimum
Mar 31, 2021
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 2.21K |
---|---|
min | 0.01 |
max | 17.91 |
average | 4.41 |
median | 3.01 |
std | 4.02 |